Abramson Cancer Center at University of Pennsylvania Medical Center is a clinical research site located in Philadelphia, Pennsylvania, United States 19104-4283.
Crixeo Health Trust Score: 79/100 (FAIR). This profile has not yet been claimed by the site owner.
Abramson Cancer Center at University of Pennsylvania Medical Center has participated in 15 clinical trials with 2 currently active.
Therapeutic areas: Cervical Cancer, Brain and Central Nervous System Tumors, Carcinoma of Unknown Primary.
Sponsors: Gynecologic Oncology Group, National Cancer Institute (NCI), European Organisation for Research and Treatment of Cancer - EORTC.
Trust Score: 79/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Abramson Cancer Center at University of Pennsylvania Medical Center has a Crixeo Trust Score of 79/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Abramson Cancer Center at University of Pennsylvania Medical Center has 15 clinical trials on record, with 2 currently active. Their work covers Cervical Cancer, Brain and Central Nervous System Tumors, Carcinoma of Unknown Primary.
Yes — Abramson Cancer Center at University of Pennsylvania Medical Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.